title: Low plasma aldosterone despite normal plasma renin activity in uncomplicated type 1 diabetes mellitus: effects of RAAS stimulation.
abstract: BACKGROUND
  Data on levels and responsiveness of PRA and aldosterone in type 1 diabetes mellitus are conflicting. Earlier studies were not standardized with respect to the type of diabetes mellitus, the presence of diabetic complications or sodium intake. Therefore, we studied plasma renin activity and plasma aldosterone in uncomplicated type 1 diabetes mellitus by evaluating the effects of endogenous (sodium restriction) and exogenous (angiotensin I infusion) stimulation.
  
  
  METHODS
  Twenty-four type 1 diabetic patients and 24 matched healthy subjects were studied after 1 week of liberal sodium diet (200 mmol 24 h-1) and 1 week of low sodium diet (50 mmol 24 h-1). Angiotensin (Ang)I was infused at 4 and 8 ng kg-1 min-1 during both study days.
  
  
  RESULTS
  During liberal and low sodium intake, plasma aldosterone was lower in type 1 diabetic patients compared with healthy subjects both at 08:00 h (P < 0.05) and after a 2-h euglycaemic clamp (P < 0.05), despite similar PRA levels. The correlations between changes in PRA and changes in plasma aldosterone when shifting sodium intake were similar in both groups. During liberal sodium intake, the aldosterone levels after AngI infusion were lower in type 1 diabetic patients, whereas during low sodium they were not different.
  
  
  CONCLUSIONS
  Plasma aldosterone was deceased relative to PRA in uncomplicated type 1 diabetic patients, irrespective sodium intake. The responsiveness to sodium restriction was adequate and sodium restriction was able to overcome the decreased plasma aldosterone response to exogenous AngI, which was observed during liberal sodium in diabetic patients. The lower aldosterone is not secondary to diabetic complications and does not depend on the level of sodium intake.
authors.affiliation: University Hospital Groningen, and Martini Ziekenhuis, Groningen, the Netherlands.
authors.forename: P T
authors.initials: PT
authors.lastname: Luik
authors.forename: M N
authors.initials: MN
authors.lastname: Kerstens
authors.forename: K
authors.initials: K
authors.lastname: Hoogenberg
authors.forename: G J
authors.initials: GJ
authors.lastname: Navis
authors.forename: R P F
authors.initials: RP
authors.lastname: Dullaart
mesh_terms: D000328:Adult; D000450:Aldosterone / Q000097:blood*; D000803:Angiotensin I / Q000008:administration & dosage; D001786:Blood Glucose / Q000032:analysis; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D004039:Diet, Sodium-Restricted / Q000379:methods; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D012083:Renin / Q000097:blood*; D012084:Renin-Angiotensin System / Q000502:physiology*
chemical_list: D001786:Blood Glucose; D000450:Aldosterone; D000803:Angiotensin I; D012083:Renin